Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about China's Huagai Capital Leads $146M Round In Haihe Biopharma
Venture Capital

China's Huagai Capital Leads $146M Round In Haihe Biopharma

by dealstreetasia.com posted 6days ago 12 views
Yingke PE, CSPC, Hillhouse Capital, Chinese Academy of Sciences Venture Capital, Atlas Capital, Boyuan Capital, Elite Capital, and Daehwa Pharmaceutical also participated in the round. The post China’s Huagai Capital leads $146m round in HaiHe Biopharma appeared first on DealStreetAsia.